Ardea Biosciences, Inc. (RDEA) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by AstraZeneca
admin2012-04-30T15:22:03+00:00April 23, 2012 Bernstein Liebhard LLP is investigating whether the Board of Directors of Ardea Biosciences, Inc. (“Ardea” or the “Company”) (NASDAQ: REDA) breached its fiduciary [...]
Knology, Inc. (KNOL) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by WOW! Internet, Cable & Phone
admin2012-04-30T14:39:27+00:00April 18, 2012 Bernstein Liebhard LLP is investigating whether the Board of Directors of Knology, Inc. (“Knology” or the “Company”) (NASDAQ: KNOL) breached its fiduciary duty [...]
Bernstein Liebhard LLP Investigates The Edelman Financial Group Inc.’s Going Private Transaction
admin2012-04-30T14:30:51+00:00April 16, 2012 Bernstein Liehhard LLP is investigating whether the Board of Directors of The Edelman Financial Group Inc. (“TEFG” or the “Company”) (NASDAQ: EF) is [...]
Bernstein Liebhard LLP Announces Investigation Into JDA Software Group Inc.
admin2012-04-30T14:22:54+00:00April 11, 2012 Bernstein Liebbard LLP today announced an investigation into possible securities law violations involving JDA Software Group Inc. (“JDA” or the “Company’) (NASDAQ: JDAS). [...]
X-Rite, Incorporated (XRIT) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by Danaher Corporation
admin2012-04-30T14:10:42+00:00April 10, 2012 Bernstein Liebhard LLP is investigating whether the Board of Directors of X-Rite, Incorporated (“X-Rite” or the “Company”) (NASDAQ: XRIT) breached its fiduciary duty [...]
eResearchTechnology, Inc. (ERT) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition by Affiliates of Genstar Capital LLC
admin2012-04-27T21:20:34+00:00April 10, 2012 Bernstein Liehhard LLP is investigating whether the Board of Directors of eResearchTechnology, Inc. (“ERT” or the “Company”) (NASDAQ: ERT) breached its fiduciary duty [...]
Allos Therapeutics, Inc. (ALTH) Shareholder Alert: Bernstein Liebhard LLP Announces Investigation of Acquisition By Spectrum Pharmaceuticals
admin2012-04-27T21:08:50+00:00April 5, 2012 Under the terms of the agreement, Allos shareholders will receive $1.82 in cash plus one Contingent Value Right (CVR) for each share they [...]
Bernstein Liebhard LLP Announces Investigation of Acquisition of Opnext, Inc. by Oclaro, Inc.
admin2012-04-27T19:54:38+00:00March 27, 2012 Bernstein Liebherd LLP is investigating whether the Board of Directors of Opnext, Inc. (“Opnext” or the “Company”) (NASDAQ: OPXI) breached its fiduciary duty [...]
Bernstein Liebhard LLP Announces Investigation of Acquisition of ISTA Pharmaceuticals, Inc. by Bausch + Lomb
admin2012-04-27T19:38:32+00:00March 27, 2012 Bernstein Liebhard LLP is investigating whether the Board of Directors of ISTA Pharmaceuticals, Inc. (“ISTA” or the “Company”) (NASDAQ: ISTA) breached its fiduciary [...]
Bernstein Liebhard LLP Announces Investigation of Acquisition of AboveNet, Inc. (ABVT) by Zayo Group, LLC
admin2012-04-27T19:29:28+00:00March 19, 2012 Bernstein Liebhard LLP is investigating whether the Board of Directors of AboveNet, Inc. (“AboveNet” or the “Company’) (NYSE: ABVT) breached its fiduciary duty [...]
Leave A Comment